O’Melveny Worldwide

Life Sciences

  • Brii Biosciences Limited in its US$318 million IPO, US$260 million Series A and Series B financings, $155 million Series C financing
  • Pharmaron in its various strategic acquisitions and investments
  • Haohai Biotech in its various strategic acquisitions and investments
  • Optovue in its equity financings and sale to Luneau
  • Hua Medicine in its US$117 million Series D and Series E financings and HK$867 million IPO
  • Carbylan Therapeutics in its US$65 million IPO
  • a multinational biotechnology company in its US$120 million convertible note and equity financings, spin-off of CDMO business and related equity financings
  • a multinational gene and cell therapy company in its US$148 million Series Seed and Series A financings

Technology

  • Dragonfly Energy Corp., an energy provider and battery producer, in its definitive business combination with a Nasdaq-listed SPAC company, which will make it a public company valued at US$500 million
  • Coinbase in its acquisition of FairX
  • WeWork in its various strategic acquisitions and joint ventures
  • Mitsui in its sale of OSIsoft to AVEVA Group
  • Blue Focus in its proposed business combination with legacy Acquisition Corp
  • Bitmain in its datacenter joint venture with Merkle Standard
  • Antpool in its datacenter joint venture with Applied Blockchain
  • SigOpt in its equity financings and sale to Intel
  • Gladly in its US$86 million Series C and Series D financings
  • Yellowbrick in its $156 million Series C and Series C1 financings
  • Tricentis in its US$165 million Series B financing
  • Finisar in its 34 Act counseling and sale to II-VI Incorporated
  • Ultratech in its 34 Act counseling and sale to Veeco
  • eHi Car Services in its Regulation S private offering of US$400 million Senior Unsecured Notes
  • a Chinese public semiconductor company in its various strategic acquisitions of US and Japanese semiconductor companies
  • the fintech arm of an e-commerce multinational conglomerate in its various strategic investments and acquisitions of US fintech companies
  • an autonomous driving technology company in its sale to a transportation network company

Languages

  • Mandarin Chinese

Admissions

Bar Admissions

  • California
  • New York

Education

  • Washington University School of Law, J.D., Dean's List
  • Washington University School of Law, LL.M., with honors
  • Shanghai Normal University, LL.B., with honors

Professional Activities

Extern

  • Office of Compliance Inspections and Examinations, Securities and Exchange Commission

Co-author

  • “Decentralized Autonomous Organizations (DAOs): Overview” (Thomson Reuters Practical Law, November 2022)
  • “Joint Ventures in Emerging Markets: the Keys to Success” (Financier Worldwide, June 2012)

Leadership

  • Advisor, Project Entrepreneur 2020 NYC, presented by UBS in partnership with The Female Founder Collective

Speaking Engagements

  • Panelist, “Asian American and Pacific Islander (AAPI) Founders Panel,” Singapore Global Network and CoffeeSpace (May 25, 2023)
  • “Decentralized Automated Organizations (DAOs): Practical Applications and Legal Framework,” Practising Law Institute (November 16, 2022)
  • “What the DAO: The Latest Blockchain Craze and What it Means For You,” DeFI and DAO Summit, NFT Next Fest (September 15, 2022)
  • Panelist, “Technology,” The Future of US and China Conference, Asia Society Northern California (January 14, 2021)